Microeconomics
- All
- AI
- Markets
- Macroeconomics
These Detroit automakers have found a financial workaround to help EV customers continue to get the federal tax credit.
Pfizer Inc. (NYSE:PFE) is one of the Best and Cheap Stocks to Buy Right Now. On September 30, Reuters reported that Pfizer Inc. (NYSE:PFE) and President Donald Trump had announced a deal to lower Medicaid drug prices in the US. The company agreed to match
Sir Keir Starmer, to his party faithful in Liverpool for last week’s annual conference, said: “A Labour party that cannot control spending is a Labour Government that cannot govern.
This is how the market performed this week
The investments over several years could be funneled into plants — including re-openings, hiring and new models — in states such as Illinois and Michigan, the people said. Stellantis is focused on reclaiming the past success of the Jeep brand and is cons
President Trump said this week that Americans could receive a cut of tariff revenue. Here's why it might be a good idea to invest those funds in Bitcoin.
Financial educator Robert Kiyosaki expressed concerns over Warren Buffett‘s recent endorsement of gold and silver investments, hinting at a possible market crash. In a post on X, Kiyosaki expressed astonishment at Buffett’s newfound interest in precious m
Uber's stock has reached new heights through the first three quarters of 2025.
We recently published 10 Stocks With Eye-Popping Double-Digit Gains. Oscar Health Inc. (NYSE:OSCR) is one of the top performers on Friday. Oscar Health extended its rally to a second day on Friday to come close to its 52-week high, as investors cheered Pr
The Federal Reserve trimmed its benchmark rate by 0.25 percentage points. But what impact does that have on cyclical stocks like Tesla? Find out more.
CNH Industrial (NYSE:CNH) has seen its short interest dip by over 5% since the last reporting period. However, the company’s overall short position remains notably higher than its industry peers. See our latest analysis for CNH Industrial. While short bet
F5 (FFIV) shares have been steady lately, coming off small moves over the past week and month. Investors are focusing on how the company's fundamentals might support its current valuation in the tech space. See our latest analysis for F5. F5's momentum ha
Interactive Brokers Group has seen its Fair Value Estimate increase slightly from $66.22 to $67.44. This reflects analysts’ updated targets following the recent quarterly results. The change is supported by strong demand across the company’s products and
Maze Therapeutics (MAZE) gained nearly 2% today as the stock continued its surge from the past month. Shares have risen almost 78% during this period. Investors are watching to see if this momentum holds. See our latest analysis for Maze Therapeutics. Maz
Real Matters stock has attracted renewed attention as the consensus analyst price target increased from CA$7.18 to CA$8.02. This modest upward adjustment highlights growing analyst confidence, with research coverage now emphasizing the company’s strong pe